Type 2 Diabetes Mellitus Clinical Trial
Official title:
Nutrition Studies and Dietary Intervention in Individuals With Type 2 Diabetes Mellitus of Chinese, Malay and Indian Ethnicity
Lifestyle modification, in particular adopting an appropriate dietary pattern, is generally
accepted as the cornerstone for the treatment of people with type 2 diabetes mellitus
(T2DM). Consumption of low glycaemic index (GI) meals have been shown to improve glycaemic
control, lipid profile and reduced systemic inflammation. However, these studies and
international evidence-based nutritional recommendations are principally based on people of
European ethnicity consuming fairly typical "western" diets. There are few published
controlled dietary intervention studies which have attempted to determine appropriate
dietary patterns for the treatment of diabetes amongst populations consuming rice-based
diets.
HYPOTHESIS
1. The glycaemic response over 6 days as measured by CGMS will have a lower mean glucose
level and postprandial increase in individuals consuming the LGI compared with the SDI
meal plan.
2. A LGI meal plan is acceptable and participants will adhere and comply to the diet to
the same level as those receiving the SDI meal plan.
3. Glycaemic and metabolic parameters as measured by integrated area under the curve
(IAUC) of glucose and insulin are lower after a single meal comprising of LGI than
compared with an SDI meal.
4. The effect of a single meal of LGI reduces appetite and increases satiety compared with
a meal of SDI.
This study builds on the information collected from phase 1 which involved the documentation
of clinical and metabolic characteristics and dietary practices of Chinese individuals with
T2DM. In addition to information from a separate study on GI testing of locally consumed
carbohydrate containing foods, we have formulated a meal plan comprising of low GI
carbohydrates. Participants will be randomised into the low GI (LGI) intervention arm or
standard dietary intervention (SDI) arm and receive counselling and advice from a dietitian,
embark on a two week protocol to test the recommended diet, be reviewed by the dietitian,
and undergo a 3 to 6 day continuous glucose monitoring period before and after the LGI or
SDI diet. In addition, they will undergo 2 separate single day test meals comprising of low
GI and high GI foods. Participants in both groups will be given resources including detailed
instructions and meal plans that are comparable between the two arms in terms of contact
with research personnel, instructions and meal plans which are isocaloric and have similar
macronutrient composition appropriate for their energy requirements.
Participants will be advised to continue on the meal plans and diet for a further 22 weeks.
At the second month, a telephone call will be made to the participant to review compliance.
At month 3 and month 6, participants will be asked to attend after an overnight fast from
10pm, for a blood sample, return a food diary/ recall, measurement of anthropometry and
blood pressure. In addition, they will complete a questionnaire
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02252224 -
Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance
|